Navigation Links
China Biologic Products Announces Third Quarter 2008 Results Conference Call
Date:11/11/2008

TAI'AN CITY, Shandong, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("CBP," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that it will host a conference call at 10:00 a.m. EST on Thursday, November 13, 2008, to discuss the third quarter 2008 results.

Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. The Company plans to release its earnings on November 12, 2008.

To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 888- 339-2688. International callers should dial 617-847-3007. The pass code for the call is 320 762 60.

If you are unable to participate in the call at this time, a replay will be available for 14 days starting on Thursday, November 13, 2008 at 12:00 p.m. EST. To access the replay, dial 888-286-8010, international callers should dial 617-801-6888. The conference pass code is 14755104.

About China Biologic Products, Inc.

Through its indirect majority-owned subsidiary Shandong Taibang Biological Products Co. Ltd., China Biologic Products, Inc. (the "Company"), is principally engaged in the research, development, production and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. The Company's human albumin products are mainly used to increase blood volume, and its immunoglobulin products are used for the treatment and prevention of diseases.

For more information, please contact:

Company Contact:

Mr. Y. Tristan Kuo

CFO

China Biologic Products, Inc.

Tel: +86-538-620-2206

Email: IR@chinabiologic.com

Web: http://www.chinabiologic.com

Investor Relations Contact:

Mr. Crocker Coulson

President

CCG Investor Relations

Tel: +1-646-213-1915 (NY office)

Email: crocker.coulson@ccgir.com

Web: http://www.ccgirasia.com


'/>"/>
SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
2. China Clean Energy Resumes Biodiesel Production After Temporary Halt
3. China Medicine Announces Conference Call to Discuss Third Quarter 2008 Results
4. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
5. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2008 Results
6. China Pharma Holdings, Inc. to Present at Two Upcoming U.S. Investor Conferences
7. China Yingxia to Present at Roth China Comes to Vegas Conference
8. PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress
9. Sinovac Named to Deloitte Technology Fast 50 China
10. Sundia MediTech Ranked #16 in Deloitte Technology Fast 50 China
11. China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
(Date:3/22/2017)... 22, 2017   Boston Biomedical , an industry ... to target cancer stemness pathways, today announced its Board ... as Chief Executive Officer, effective April 24, 2017. ... Li , M.D., FACP, who has led Boston Biomedical ... his leadership, Boston Biomedical has grown from a "garage ...
Breaking Biology Technology:
(Date:2/27/2017)... 2017   Strategic Cyber Ventures , the industry,s ... a $3.5 million investment in  Polarity , the first ... is DC based and is led by cybersecurity veterans ... Ron Gula , also a longtime cybersecurity veteran ... this series A round of funding. This new funding ...
(Date:2/24/2017)... Spain , Feb. 24, 2017  EyeLock LLC, a ... demonstrate its elite iris biometric solution on the ... X16 LTE at Mobile World Congress 2017 ... Qualcomm,s Booth in Hall 3, Stand 3E10. ... the Qualcomm Haven™ security platform—a combination of ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):